Michael E. Kimerling

1.9k total citations
35 papers, 1.2k citations indexed

About

Michael E. Kimerling is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Michael E. Kimerling has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 27 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Michael E. Kimerling's work include Tuberculosis Research and Epidemiology (30 papers), Mycobacterium research and diagnosis (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Michael E. Kimerling is often cited by papers focused on Tuberculosis Research and Epidemiology (30 papers), Mycobacterium research and diagnosis (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Michael E. Kimerling collaborates with scholars based in United States, Switzerland and Netherlands. Michael E. Kimerling's co-authors include Nancy E. Dunlap, Patricia Patterson, C. Andrew Robinson, Penny Phillips, Jay K. Varma, Phalkun Chheng, Kimberly D. McCarthy, Patama Monkongdee, Kevin P. Cain and William A. Wells and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Michael E. Kimerling

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Kimerling United States	20	1.1k	885	427	65	55	35	1.2k
César Antonio Bonilla-Asalde Peru	19	765 0.7×	616 0.7×	307 0.7×	43 0.7×	49 0.9×	61	1.0k
Themba Moeti Botswana	13	761 0.7×	593 0.7×	256 0.6×	64 1.0×	87 1.6×	22	958
Sundari Mase United States	17	982 0.9×	751 0.8×	437 1.0×	33 0.5×	39 0.7×	41	1.1k
Ian Sanne South Africa	16	800 0.8×	602 0.7×	229 0.5×	74 1.1×	52 0.9×	31	959
Anne Efron United States	12	861 0.8×	650 0.7×	199 0.5×	60 0.9×	48 0.9×	13	976
Norbert Ndjeka South Africa	19	1.1k 1.1×	815 0.9×	320 0.7×	124 1.9×	100 1.8×	55	1.3k
Andrea Benedetti Canada	23	1.6k 1.5×	1.1k 1.2×	688 1.6×	53 0.8×	65 1.2×	49	1.8k
Jennifer Hughes South Africa	23	1.3k 1.3×	1.0k 1.1×	441 1.0×	66 1.0×	114 2.1×	56	1.5k
R. Kevin Elwood Canada	19	614 0.6×	469 0.5×	384 0.9×	51 0.8×	25 0.5×	34	979
N. Sarita Shah United States	13	1.1k 1.0×	885 1.0×	450 1.1×	49 0.8×	26 0.5×	19	1.2k

Countries citing papers authored by Michael E. Kimerling

Since Specialization

Citations

This map shows the geographic impact of Michael E. Kimerling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Kimerling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Kimerling more than expected).

Fields of papers citing papers by Michael E. Kimerling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Kimerling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Kimerling. The network helps show where Michael E. Kimerling may publish in the future.

Co-authorship network of co-authors of Michael E. Kimerling

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Kimerling. A scholar is included among the top collaborators of Michael E. Kimerling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Kimerling. Michael E. Kimerling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pedrazzoli, Debora, Delia Boccia, Peter J. Dodd, et al.. (2017). Modelling the social and structural determinants of tuberculosis: opportunities and challenges. The International Journal of Tuberculosis and Lung Disease. 21(9). 957–964. 39 indexed citations

Houben, Rein M G J, David W. Dowdy, Anna Vassall, et al.. (2014). How can mathematical models advance tuberculosis control in high HIV prevalence settings?. The International Journal of Tuberculosis and Lung Disease. 18(5). 509–514. 19 indexed citations

Heilig, Charles M., Michael E. Kimerling, Nguyễn Đức Huy, et al.. (2013). The utility of stool cultures for diagnosing tuberculosis in people living with the human immunodeficiency virus. The International Journal of Tuberculosis and Lung Disease. 17(8). 1023–1028. 16 indexed citations

Wells, William A., Catharina Boehme, Frank Cobelens, et al.. (2013). Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. The Lancet Infectious Diseases. 13(5). 449–458. 42 indexed citations

McCarthy, Kimberly D., Kevin P. Cain, Kevin Winthrop, et al.. (2012). Nontuberculous Mycobacterial Disease in Patients with HIV in Southeast Asia. American Journal of Respiratory and Critical Care Medicine. 185(9). 981–988. 45 indexed citations

Arentz, Matthew, Patricia B. Pavlinac, Michael E. Kimerling, et al.. (2012). Use of Anti-Retroviral Therapy in Tuberculosis Patients on Second-Line Anti-TB Regimens: A Systematic Review. PLoS ONE. 7(11). e47370–e47370. 22 indexed citations

Cobelens, Frank, Susan van den Hof, Madhukar Pai, et al.. (2012). Which New Diagnostics for Tuberculosis, and When?. The Journal of Infectious Diseases. 205(suppl_2). S191–S198. 44 indexed citations

Wells, William A., et al.. (2011). Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries. PLoS ONE. 6(5). e18964–e18964. 88 indexed citations

Wongsrichanalai, Chansuda, Jay K. Varma, Jonathan J. Juliano, Michael E. Kimerling, & John R. MacArthur. (2010). Extensive Drug Resistance in Malaria and Tuberculosis. Emerging infectious diseases. 16(7). 1063–1067. 14 indexed citations

10.

Varma, Jay K., Kimberly D. McCarthy, Theerawit Tasaneeyapan, et al.. (2010). Bloodstream Infections among HIV-Infected Outpatients, Southeast Asia. Emerging infectious diseases. 16(10). 1569–1575. 20 indexed citations

11.

Cain, Kevin P., Kimberly D. McCarthy, Charles M. Heilig, et al.. (2010). An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV. New England Journal of Medicine. 362(8). 707–716. 202 indexed citations

12.

Tamhane, Ashutosh, et al.. (2009). Predictors of smear-negative pulmonary tuberculosis in HIV-infected patients, Battambang, Cambodia.. PubMed. 13(3). 347–54. 16 indexed citations

13.

Cobelens, Frank, Einar Heldal, Michael E. Kimerling, et al.. (2008). Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda. PLoS Medicine. 5(7). e150–e150. 35 indexed citations

14.

Mahendradhata, Yodi, Riris Andono Ahmad, Marleen Boelaert, et al.. (2008). Voluntary counselling and testing uptake and HIV prevalence among tuberculosis patients in Jogjakarta, Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 102(10). 1003–1010. 13 indexed citations

15.

Eang, Mao Tan, Phalkun Chheng, Chawalit Natpratan, & Michael E. Kimerling. (2007). Lessons from TB/HIV integration in Cambodia. Bulletin of the World Health Organization. 85(5). 382–383. 4 indexed citations

16.

Mello, Fernanda Carvalho de Queiroz, Senia Rosales-Klintz, Mônica Kramer de Noronha Andrade, et al.. (2007). Clinical Evaluation of the Microscopic-Observation Drug-Susceptibility Assay for Detection of Tuberculosis. Clinical Infectious Diseases. 44(5). 674–780. 52 indexed citations

17.

Mello, Fernanda Carvalho de Queiroz, Senia Rosales-Klintz, Mônica Kramer de Noronha Andrade, et al.. (2007). Clinical Evaluation of the Microscopic Observation Drug Susceptibility Assay for Detection of Mycobacterium tuberculosis Resistance to Isoniazid or Rifampin. Journal of Clinical Microbiology. 45(10). 3387–3389. 27 indexed citations

18.

Gerald, Lynn B., F. Carol Bruce, C. Michael Brooks, et al.. (2003). Standardizing contact investigation protocols.. PubMed. 7(12 Suppl 3). S369–74. 13 indexed citations

19.

Gerald, Lynn B., Shenghui Tang, F. Carol Bruce, et al.. (2002). A Decision Tree for Tuberculosis Contact Investigation. American Journal of Respiratory and Critical Care Medicine. 166(8). 1122–1127. 50 indexed citations

20.

Lok, Kerry H., et al.. (2002). Molecular Typing ofMycobacterium tuberculosisStrains with a Common Two-Band IS6110Pattern. Emerging infectious diseases. 8(11). 1303–1305. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact